The scientific and regulatory rationale for indication extrapolation: a case study based on the infliximab biosimilar CT-P13 (vol 9, pg 17, 2015) / Reinisch, W; Louis, E; Danese, S. - In: EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY. - ISSN 1747-4124. - 10:6(2016), pp. V-V. [10.1080/17474124.2016.1178990]
The scientific and regulatory rationale for indication extrapolation: a case study based on the infliximab biosimilar CT-P13 (vol 9, pg 17, 2015)
Danese S
2016-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.